Philip Morris International (PM)
(Delayed Data from NYSE)
$125.62 USD
+0.97 (0.78%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $125.61 -0.01 (-0.01%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$125.62 USD
+0.97 (0.78%)
Updated Sep 13, 2024 04:00 PM ET
After-Market: $125.61 -0.01 (-0.01%) 7:58 PM ET
2-Buy of 5 2
D Value B Growth C Momentum C VGM
Zacks News
Jobless Claims Steady; Mixed Q4 for AZN, HSY and PM
by Mark Vickery
We're once again reassured that employment, on a finer week-over-week scale, is not falling off a cliff.
Philip Morris (PM) Lags Q4 Earnings Estimates
by Zacks Equity Research
Philip Morris (PM) delivered earnings and revenue surprises of -5.56% and 0.98%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
The Zacks Analyst Blog Highlights Thermo Fisher Scientific, Philip Morris, General Dynamics, Becton, Dickinson, Cheniere Energy and Aflac
by Zacks Equity Research
Thermo Fisher Scientific, Philip Morris, General Dynamics, Becton, Dickinson, Cheniere Energy and Aflac are included in this Analyst Blog.
Earnings Season Scorecard and Analyst Reports for Thermo Fisher, Philip Morris & General Dynamics
by Sheraz Mian
Today's Research Daily features the real-time earnings season scorecard and updated analyst reports on Thermo Fisher (TMO), Philip Morris International (PM) and General Dynamics (GD).
Philip Morris (PM) Q4 Earnings Coming Up: What to Expect?
by Zacks Equity Research
Philip Morris' (PM) fourth-quarter results are likely to reflect strength in smoke-free products and gains from pricing power, though cigarette volumes have been declining year over year.
What Analyst Projections for Key Metrics Reveal About Philip Morris (PM) Q4 Earnings
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Philip Morris (PM), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
Philip Morris (PM) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
by Zacks Equity Research
Philip Morris (PM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Altria (MO) Q4 Earnings Beat Estimates
by Zacks Equity Research
Altria (MO) delivered earnings and revenue surprises of 0.85% and 1.20%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
Why Philip Morris (PM) is a Top Value Stock for the Long-Term
by Zacks Equity Research
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Why Philip Morris (PM) Outpaced the Stock Market Today
by Zacks Equity Research
The latest trading day saw Philip Morris (PM) settling at $91.70, representing a +0.94% change from its previous close.
Here's What's in Store for Diageo (DEO) in 1H24 Earnings
by Zacks Equity Research
Diageo's (DEO) first-half fiscal 2024 results are likely to reflect gains from a diversified footprint, advantaged portfolio, strong brands and favorable industry trends of premiumization.
McCormick (MKC) Q4 Earnings Coming Up: Factors to Consider
by Zacks Equity Research
McCormick's (MKC) fourth-quarter performance is likely to reflect gains from pricing actions and cost savings. Focus on the GOE programs is likely to contribute to the upside.
Philip Morris (PM) Increases Yet Falls Behind Market: What Investors Need to Know
by Zacks Equity Research
In the most recent trading session, Philip Morris (PM) closed at $92.43, indicating a +0.12% shift from the previous trading day.
Things to Consider Before Kimberly-Clark's (KMB) Q4 Earnings
by Zacks Equity Research
Kimberly-Clark's (KMB) fourth-quarter performance is likely to reflect gains from revenue growth management and cost-saving efforts amid inflationary headwinds.
Philip Morris (PM) Poised Well on Pricing, Smoke-Free Strength
by Zacks Equity Research
Philip Morris (PM) benefits from its robust pricing power and focus on smoke-free alternatives amid consumers' growing health consciousness.
Why Investors Need to Take Advantage of These 2 Consumer Staples Stocks Now
by Zacks Equity Research
Finding stocks expected to beat quarterly earnings estimates becomes an easier task with our Zacks Earnings ESP.
Will Philip Morris (PM) Beat Estimates Again in Its Next Earnings Report?
by Zacks Equity Research
Philip Morris (PM) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Philip Morris (PM) Rises Yet Lags Behind Market: Some Facts Worth Knowing
by Zacks Equity Research
In the closing of the recent trading day, Philip Morris (PM) stood at $96.29, denoting a +1.04% change from the preceding trading day.
The Zacks Analyst Blog Highlights Merck, Salesforce, Philip Morris International, Novartis and CME Group
by Zacks Equity Research
Merck, Salesforce, Philip Morris International, Novartis and CME Group are part of the Zacks top Analyst Blog.
Top Analyst Reports for Merck, Salesforce & Philip Morris
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including Merck & Co., Inc. (MRK), Salesforce, Inc. (CRM) and Philip Morris International Inc. (PM).
Things to Consider Before Helen of Troy's (HELE) Q3 Earnings
by Zacks Equity Research
Helen of Troy's (HELE) third-quarter performance is likely to reflect pressure from the adverse impact of a continued slower economy and uncertainty in spending patterns.
Philip Morris' (PM) Focus on Smoke-Free Products to Aid in 2024
by Zacks Equity Research
Philip Morris' (PM) strong pricing power and focus on smoke-free products provide some cushion against soft cigarette shipment volumes and the impacts of inflation.
Philip Morris (PM) Rises As Market Takes a Dip: Key Facts
by Zacks Equity Research
The latest trading day saw Philip Morris (PM) settling at $95.56, representing a +1.57% change from its previous close.
Lamb Weston (LW) Q2 Earnings Coming Up: Factors to Note
by Zacks Equity Research
Lamb Weston's (LW) second-quarter fiscal 2024 performance is likely to reflect benefits from effective pricing and a solid operating momentum. Capacity expansion efforts are also an upside.
What's in Store for Constellation Brands' (STZ) Q3 Earnings?
by Zacks Equity Research
Constellation Brands' (STZ) Q3 results are expected to reflect strength in the beer business and gains from the premiumization strategy.